Livalozet vs. High-Dose Statin for Older Heart Patients
Part of Heart & circulation clinical trials.
This study compares two cholesterol-lowering medications—livalozet and high-dose statin—in patients age 75 and older who have heart disease and need a procedure to open blocked arteries. The goal is to see which treatment works better and is safer for older adults.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 75 years old or older
- You have been diagnosed with coronary artery disease (narrowed heart arteries) and need a procedure to open a blocked artery
- You have high cholesterol or mixed cholesterol and triglyceride problems
- You do not have a severe allergy or bad reaction to statins or ezetimibe (cholesterol medicines)
- Your liver is working normally and liver enzyme levels are not dangerously high
- You are able to understand the study and commit to follow-up visits
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares a lower-dose cholesterol pill (rosuvastatin plus ezetimibe) to a higher-dose version of just rosuvastatin for people with mild to moderate heart artery blockages who have not had a stent or bypass. It aims to see which approach works better and is safer.
This trial compares two cholesterol-lowering treatment plans after a heart procedure where new drug-eluting stents were placed: a combination of high-intensity statin plus ezetimibe versus high-intensity statin alone. It may help find which option lowers cholesterol more effectively and safely over the first year after the procedure.
This trial compares a high-dose combination of rosuvastatin (a statin) and ezetimibe (another cholesterol-lowering drug) versus a standard rosuvastatin-only approach for people with peripheral artery disease (narrowed leg arteries) or widespread artery disease. The goal is to see which strategy better lowers LDL cholesterol and reduces heart and limb risks.
This study compares two different ways of lowering cholesterol: a moderate statin (pitavastatin) plus another drug (ezetimibe) versus a stronger statin alone. The goal is to see which approach is safer regarding the risk of developing new diabetes.
This study compares two cholesterol treatment approaches after a heart attack: a lower dose combination versus a higher dose single medicine. It aims to see which option works well and is tolerable for people after a treated heart attack.
This trial tests whether adding two extra medicines to a common cholesterol-lowering statin lowers LDL ('bad') cholesterol more effectively in people recently hospitalized for a heart attack or unstable chest pain.
Hear when a new Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.